Monday, October 21, 2013

Kona Medical Raises $10M For Kidney Treatment Device

Bellevue-based Kona Medical, the developer of ultrasound devices for treating kidney issues, said today that it has raised $10M in a Series D investment. The funding was led by Morningside Group, an investor focused on China, which is the round's sole investor. Kona Medical said the funding will go towards navigating with the clinical, regulatory, and intellectual property issues in China. Kona Medical is led by Michael Gertner. Kona Medical's ultrasound systems are aimed at trating nerves leading to the kidney, as part of treatment of hypertension. More information »